Kristiina Koskela
Papers
1
Total Citations
26
H-Index
1
About
Dr. Kristiina Koskela is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for prostate cancer. Her major contribution lies in pioneering the clinical adoption of hypofractionated SBRT as a primary treatment for localized prostate cancer, challenging conventional fractionation schedules. Her seminal 2017 paper, "Hypofractionated stereotactic body radiotherapy for localized prostate cancer – first Nordic clinical experience" (26 citations), provided crucial early evidence from the Nordic region, demonstrating the feasibility and safety of delivering high-dose-per-fraction radiation. This work helped validate the low α/β-ratio hypothesis in a real-world clinical setting, offering patients a more convenient, shorter treatment course without compromising efficacy. By generating the first Nordic clinical data, Dr. Koskela has significantly influenced regional treatment protocols and expanded the evidence base for SBRT, making her a key figure in the ongoing shift toward ultra-hypofractionation in prostate cancer care. Her research continues to shape modern radiotherapy practice.
Research Focus
Key Achievements
Top Papers
- 1